FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Ezetimibe and Simvastatin Tablets Recall

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Nov 10, 2021
Recall ID
D-0085-2022
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Dr. Reddy's Ezetimibe and Simvastatin Tablets starting Oct 5, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0085-2022 on Nov 10, 2021. Reason: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle. Status: Terminated.

Why it was recalled

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Product description

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05

Lot numbers, UPCs & expiration codes

L100208, exp 01/2023

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0085-2022
Classification
Class II
Status
Terminated
Recall initiated
Oct 5, 2021
FDA report date
Nov 10, 2021
Quantity
696 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0085-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
88798
Address
107 College Rd E
Code information
L100208, exp 01/2023
Postal code
08540-6623
Report date
Nov 10, 2021
Product type
Drugs
Recall number
D-0085-2022
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
696 bottles
Termination date
Feb 16, 2023
Reason for recall
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05
Distribution pattern
Nationwide in the US
Recall initiation date
Oct 5, 2021
Initial firm notification
Letter
Center classification date
Oct 29, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0085-2022, published Nov 10, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls